Henry Schein Q2 Adjusted EPS USD 1.27 Vs. IBES Estimate USD 1.24
HSIC•Q2 results and full-year outlook
Aug. 4 (Reuters) - Henry Schein Q2 net income USD 94 million.
- Q2 sales USD 3,500 million vs. IBES estimate USD 3,375 million
- Q2 EPS USD 0.82
- Q2 adjusted net income USD 145 million vs. IBES estimate USD 142.3 million
- outlook FY adjusted EPS USD 5.29-5.39 vs. IBES estimate USD 5.33
- outlook FY sales growth 4.5-5.5%
Related News
Larimar Therapeutics Q2 Net Income USD -32.782 Million
LRMR•
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results Highlights Key Regulatory And Clinical Milestones Across Broad, Diverse Pipeline
MRK•
